September 18, 2023
Global Fund partnership achieves record breaking results, with 59 million lives saved since 2002, thanks to U.S. investments
Washington, DC – The Global Fund partnership has saved over 59 million lives since 2002 and is achieving record breaking impact through its HIV, TB and malaria programs. The annual Global Fund Results Report, released today, notes that in 2022 there was rapid acceleration of program outcomes across the three disease responses.
In 2022, more people were initiated on HIV and TB treatment than ever before and a record number of bed nets to prevent malaria were distributed. Last year, 24.5 million people received life-saving antiretroviral treatment for HIV, 6.7 million people were treated for TB and 220 million mosquito nets were dispersed in at-risk communities. In addition, 710,000 mothers were on HIV treatment in 2022 to keep them alive and stop transmission of HIV to their babies. These numbers exceed even pre-COVID-19 levels.
“These outcomes are a testament to the Global Fund’s effectiveness, innovation and impact,” said Chris Collins, president and CEO of Friends of the Global Fight. “After serious setbacks during the COVID-19 pandemic we are now seeing unparalleled progress. This is what happens when communities, governments, and international partners come together to save lives. These results show the unique Global Fund model in action, and they are made possible by sustained, bipartisan U.S. leadership over the last two decades.”
Despite the hopeful progress in 2022, the world is not on track to end the AIDS, TB and malaria epidemics by 2030, a UN Sustainable Development Goal. Challenges have only compounded in recent years, with climate change creating new breeding grounds for mosquitoes and global conflict disrupting medical care and treatment. There is also a need for more equitable access to innovative new tools, such as mobile x-rays for TB and treatments for pediatric HIV.
“While the latest numbers are very encouraging, more needs to be done if we are going to end these epidemics once and for all,” said Jeffrey L. Sturchio, Friends’ Board chair and past chairman and CEO of Rabin Martin, a global health impact consultancy. “We need bigger, more sustained investments. U.S. leadership should be center stage in scaling up innovative treatments and tools. The end of the AIDS, TB and malaria epidemics are in sight, but only if we make these diseases an urgent global priority.”
ABOUT FRIENDS OF THE GLOBAL FIGHT AGAINST AIDS, TUBERCULOSIS AND MALARIA:
Friends of the Global Fight Against AIDS, Tuberculosis and Malaria advocates for U.S. support of the Global Fund, and the goal to end the epidemics of AIDS, tuberculosis and malaria. For more information about Friends of the Global Fight, visit www.theglobalfight.org.
ABOUT THE GLOBAL FUND:
The Global Fund is a partnership designed to accelerate the end of AIDS, tuberculosis and malaria as epidemics. As an international organization, the Global Fund mobilizes and invests more than US$4 billion a year to support programs run by local experts in more than 120 countries. In partnership with governments, civil society, technical agencies, the private sector, faith-based organizations and people affected by the diseases, we are challenging barriers and embracing innovation. Learn more at https://www.theglobalfund.org/en/overview.